Invokana is a SGLT2 inhibitor designed to treat those with Type 2 Diabetes, but it has been linked to ketoacidosis, a serious complication where the body produces excess ketones, resulting in symptoms including excessive thirst, frequent urination, nausea and vomiting and abdominal pain. It has also been linked to cases of kidney failure. If you or a loved one has suffered from ketoacidosis or experienced kidney problems after taking Invokana, VanDerGinst Law can help.